Jeffrey S. Painter

1.8k citations

28 papers · 1.3k indexed · h-index 16

Co-authors: William S. Dalton Terry H. Landowski I Buyuksal Ning Qu Pearlie K. Epling‐Burnette Fanqi Bai Alan F. List JianXiang Zou
Topics: Acute Myeloid Leukemia Research (13 papers)Immune Cell Function and Interaction (11 papers)Chronic Lymphocytic Leukemia Research (8 papers)
Cited by: Hematology Genetics Immunology
Journals: Blood Oncogene Leukemia
Partner nations: United States Germany China

In The Last Decade

Jeffrey S. Painter

27 papers receiving 1.3k citations

Peers

Countries citing papers authored by Jeffrey S. Painter

Since Specialization

Citations

This map shows the geographic impact of Jeffrey S. Painter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey S. Painter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey S. Painter more than expected).

Fields of papers citing papers by Jeffrey S. Painter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey S. Painter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey S. Painter. The network helps show where Jeffrey S. Painter may publish in the future.

Co-authorship network of co-authors of Jeffrey S. Painter

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey S. Painter. A scholar is included among the top collaborators of Jeffrey S. Painter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey S. Painter. Jeffrey S. Painter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Failure to Detect Mutations in U2AF1 due to Changes in the GRCh38 Reference Sequence 2022 ·Journal of Molecular Diagnostics ·Christopher A. Miller,Jason Walker,(unknown),(unknown),Robert S. Fulton,Jeffrey S. Painter,Mikkael A. Sekeres,Timothy J. Ley,David H. Spencer,Johannes B. Goll,Matthew J. Walter	14
2	GM-CSF–dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia 2013 ·Blood ·Eric Padron,Jeffrey S. Painter,Sateesh Kunigal,Adam W. Mailloux,Kathy L. McGraw,(unknown),Eun Hee Kim,Christopher Bebbington,Mark Baer,Geoffrey Yarranton,Jeffrey E. Lancet,Rami S. Komrokji,Omar Abdel‐Wahab,Alan F. List,Pearlie K. Epling‐Burnette	108
3	Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiency 2012 ·Leukemia ·Yang Liu,Adam W. Mailloux,Dana E. Rollison,Jeffrey S. Painter,Jaroslaw P. Maciejewski,Ronald Paquette,Thomas P. Loughran,Kathy L. McGraw,Hideki Makishima,Rangasudhagar Radhakrishnan,Sheng Wei,Xiubao Ren,Rami S. Komrokji,Alan F. List,P.K. Epling-Burnette	17
4	Preclinical Characterization of KB003, a Novel Humaneered™ Monoclonal Anti-GM-CSF Antibody, Demonstrates That the GM-CSF Signaling Axis Is a Therapeutic Target in Chronic Myelomonocytic Leukemia (CMML) 2012 ·Blood ·Eric Padron,Jeffrey S. Painter,Adam W. Mailloux,Kathy L. McGraw,(unknown),Christopher Bebbington,Mark Baer,Geoffrey Yarranton,Jeffrey E. Lancet,Rami S. Komrokji,Alan F. List,Pearlie K. Epling‐Burnette	0
5	Tipifarnib-mediated suppression of T-bet-dependent signaling pathways 2011 ·Cancer Immunology Immunotherapy ·Fanqi Bai,Alejandro Villagra,(unknown),Jeffrey S. Painter,(unknown),Michelle A. Blaskovich,Lubomir Sokol,Saı̈d M. Sebti,Julie Y. Djeu,Thomas P. Loughran,Sheng Wei,Eduardo M. Sotomayor,Pearlie K. Epling‐Burnette	4
6	Telomere length in myelodysplastic syndromes 2011 ·Leukemia & lymphoma ·Dana E. Rollison,P.K. Epling-Burnette,Jong Y. Park,Ji‐Hyun Lee,(unknown),(unknown),Ashley L. Cole,Jeffrey S. Painter,(unknown),(unknown),William J. Fulp,Rami S. Komrokji,Jeffrey E. Lancet,Alan F. List	43
7	GM-CSF Signaling Abnormalities in Chronic Myelomonocytic Leukemia 2011 ·Blood ·Eric Padron,Jeffrey S. Painter,Adam W. Mailloux,(unknown),Christopher Bebbington,Mark Baer,Rami S. Komrokji,Alan F. List,Pearlie K. Epling‐Burnette	2
8	Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome 2009 ·Leukemia ·JianXiang Zou,Dana E. Rollison,David Boulware,(unknown),Elaine M. Sloand,Loretta Pfannes,Jörg J. Goronzy,Fanqi Bai,Jeffrey S. Painter,Sheng Wei,Denise Cosgrove,Alan F. List,Pearlie K. Epling‐Burnette	45
9	Positive Impact of T-Cell Clonal Expansion On Overall Survival in Patients with High-Risk Myelodysplastic Syndromes. 2009 ·Blood ·(unknown),Rami S. Komrokji,Jeffrey S. Painter,Dana E. Rollison,Ling Zhang,Lynn C. Moscinski,Alan F. List,P.K. Epling-Burnette	1
10	Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling 2008 ·Blood ·Pearlie K. Epling‐Burnette,Lubomir Sokol,Xianhong Chen,Fanqi Bai,Junmin Zhou,Michelle A. Blaskovich,JianXiang Zou,Jeffrey S. Painter,(unknown),Lynn C. Moscinski,Jeffrey A. Yoder,Julie Y. Djeu,Saı̈d M. Sebti,Thomas P. Loughran,Sheng Wei	33
11	Altered Naive and Memory T Cell Homeostasis and Immunosenescence Characterize Younger Patients with Immunosuppressive-Responsive Myelodysplastic Syndrome 2008 ·Blood ·JianXiang Zou,Dana E. Rollison,David Boulware,Elaine M. Sloand,Loretta Pfannes,Fanqi Bai,Jeffrey S. Painter,Sheng Wei,Denise Cosgrove,Alan F. List,Pearlie K. Epling‐Burnette	1
12	A Comprehensive Lymphocyte Analysis of Dasatinib Treated Chronic Myelogenous Leukemia Patients Reveals T-Cell Oligoclonality. 2008 ·Blood ·John J. Powers,Jeffrey S. Painter,Jason A. Dubovsky,P.K. Epling-Burnette,(unknown)	2
13	Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome 2007 ·Leukemia ·Pearlie K. Epling‐Burnette,Jeffrey S. Painter,Dana E. Rollison,(unknown),(unknown),R Widen,David Boulware,JianXiang Zou,Fanqi Bai,Alan F. List	94
14	Th2 Polarization Induced by the Farnesyltransferase Inhibitor Tipifarnib (Zarnestra®, R115777) through Suppression of T-bet. 2007 ·Blood ·Fanqi Bai,JianXiang Zou,Wei Sheng,Jeffrey S. Painter,Michelle A. Blaskovich,Saı̈d M. Sebti,Thomas P. Loughran,Pearlie K. Epling‐Burnette	1
15	Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia 2007 ·Blood ·Jun Yang,Pearlie K. Epling‐Burnette,Jeffrey S. Painter,JianXiang Zou,Fanqi Bai,Wei Sheng,Thomas P. Loughran	63
16	ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL) 2004 ·Oncogene ·Pearlie K. Epling‐Burnette,Fanqi Bai,Sheng Wei,Pratima Chaurasia,Jeffrey S. Painter,Nancy Olashaw,Andrew D. Hamilton,Saı̈d M. Sebti,Julie Y. Djeu,Thomas P. Loughran	61
17	Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model. 2003 ·PubMed ·Lori Hazlehurst,Steven A. Enkemann,Craig A. Beam,Raul F. Argilagos,Jeffrey S. Painter,Kenneth H. Shain,(unknown),David Boulware,Lynn C. Moscinski,Melissa Alsina,William S. Dalton	107
18	CD95 Antigen Mutations in Hematopoietic Malignancies 2001 ·Leukemia & lymphoma ·Terry H. Landowski,Lynn C. Moscinski,Rachel M. Burke,I Buyuksal,Jeffrey S. Painter,Steven A. Goldstein,William S. Dalton	22
19	Myeloma Cells Selected for Resistance to CD95-Mediated Apoptosis Are Not Cross-Resistant to Cytotoxic Drugs: Evidence for Independent Mechanisms of Caspase Activation 1999 ·Blood ·Terry H. Landowski,Kenneth H. Shain,Marc M. Oshiro,I Buyuksal,Jeffrey S. Painter,William S. Dalton	51
20	Mutations in the Fas Antigen in Patients With Multiple Myeloma 1997 ·Blood ·Terry H. Landowski,Ning Qu,I Buyuksal,Jeffrey S. Painter,William S. Dalton	159

About Jeffrey S. Painter

Jeffrey S. Painter is a scholar working on Hematology, Genetics and Immunology, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (13 papers), Immune Cell Function and Interaction (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). The work is most often cited by research in Hematology (497 citations), Genetics (344 citations) and Immunology (635 citations). Jeffrey S. Painter has collaborated with scholars based in United States, Germany and China. Frequent co-authors include William S. Dalton, Terry H. Landowski, I Buyuksal, Ning Qu, Pearlie K. Epling‐Burnette, Fanqi Bai, Alan F. List, JianXiang Zou, David Boulware and Julie Y. Djeu. Their work appears in journals such as Blood, Oncogene and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact